Management of Mild Disc Space Narrowing of L5-S1

Introduction to Lidocaine Patch Therapy

The American College of Physicians and other guideline societies recommend against the use of lidocaine patches as first-line therapy for mild disc space narrowing of L5-S1, as they are primarily indicated for localized neuropathic pain rather than structural spinal issues 1, 2

Lidocaine patches work by blocking sodium channels required for neuronal impulse conduction, providing localized anesthesia without significant systemic absorption 2
The American Academy of Neurology suggests that lidocaine patches are most appropriate for well-localized neuropathic pain, not central pain or structural issues like disc space narrowing 1

The North American Spine Society recommends a multimodal approach for mild disc space narrowing at L5-S1, rather than lidocaine patches alone, with a strength of evidence rated as moderate 3, 4
Lidocaine patches have shown efficacy primarily for neuropathic pain components rather than mechanical/structural back pain, according to the World Institute of Pain 1, 3

The American College of Physicians recommends first-line options including NSAIDs or acetaminophen for inflammatory pain, and physical therapy and exercise programs specifically targeting core strengthening 1, 3, 4
The American Academy of Neurology suggests second-line options, such as gabapentinoids (gabapentin or pregabalin), if a neuropathic pain component exists, with a strength of evidence rated as high 3, 5

The FDA recommends applying lidocaine patches to intact skin only over the painful area, with a maximum of 3 patches simultaneously for 12 hours on, 12 hours off 2
The FDA also warns against excessive heat application over the patch, as it may increase systemic absorption, and recommends monitoring for signs of systemic absorption such as dizziness, confusion, and bradycardia 2, 5

The American College of Physicians notes that lidocaine patches alone are unlikely to address the underlying structural issue of disc space narrowing, and recommends reevaluation for persistent pain beyond 3-7 days 1, 3
The FDA lists contraindications, including advanced liver failure, broken skin, and hypersensitivity to amide anesthetics, and recommends being aware of potential drug interactions when using in combination with oral medications 2, 5

The World Institute of Pain suggests considering combining lidocaine patches with pregabalin for complementary mechanisms of action if neuropathic pain is present alongside structural issues, with a recommended starting dose of 50mg three times daily 5